Treatment with allogeneic mesenchymal stromal cells for moderate to severe acute respiratory distress syndrome (START study): a randomised phase 2a safety trial.
采用同种异体间充质干细胞治疗中重度急性呼吸窘迫综合征(START 研究):一项随机 2a 期安全性试验
期刊:Lancet Respiratory Medicine
影响因子:32.8
doi:10.1016/S2213-2600(18)30418-1
Matthay Michael A, Calfee Carolyn S, Zhuo Hanjing, Thompson B Taylor, Wilson Jennifer G, Levitt Joseph E, Rogers Angela J, Gotts Jeffrey E, Wiener-Kronish Jeanine P, Bajwa Ednan K, Donahoe Michael P, McVerry Bryan J, Ortiz Luis A, Exline Matthew, Christman John W, Abbott Jason, Delucchi Kevin L, Caballero Lizette, McMillan Melanie, McKenna David H, Liu Kathleen D